Heidi Ledford. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/economicsAntibodies, Monoclonal/immunologyAntibodies, Monoclonal/therapeutic useAntineoplastic Agents/economicsAntineoplastic Agents/supply & distributionAntineoplastic Agents/therapeutic useClinical Trials as TopicCombined Modality Therapy/statistics & numerical dataDrug Therapy, Combination/statistics & numerical dataHumansImmunotherapy/statistics & numerical dataIpilimumabNeoplasms/drug therapyNeoplasms/immunologyNeoplasms/radiotherapyNeoplasms/therapyNivolumab
Substances: See more » Antibodies, MonoclonalAntineoplastic AgentsIpilimumabNivolumab
Year: 2013 PMID: 23719439 DOI: 10.1038/497544a
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962